Mazzo David J 4
4 · LISATA THERAPEUTICS, INC. · Filed Oct 2, 2024
Insider Transaction Report
Form 4
Mazzo David J
DirectorPresident & CEO
Transactions
- Award
Common Stock
2024-10-01$2.93/sh+58,000$169,940→ 238,798 total - Tax Payment
Common Stock
2024-10-01$2.93/sh−26,964$79,005→ 211,834 total
Footnotes (3)
- [F1]Reflects 58,000 in performance-based stock units, the criteria for which was satisfied on October 1, 2024 and which vested in full on that same day.
- [F2]Includes 107,183 unvested restricted stock.
- [F3]Shares withheld as payment of a tax liability on vesting of performance-based stock units.